{"filing":{"accession_number":"0001104659-26-093721","cik":"0001235912","ticker":"CVRX","company_name":"CVRx, Inc.","form":"8-K","filing_date":"2026-08-11","report_date":"2026-08-10","primary_document":"tm2622791d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1235912/000110465926093721/tm2622791d1_8k.htm"},"events":[{"id":26858,"run_id":24426,"accession_number":"0001104659-26-093721","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Robert John, Chief Revenue Officer, terminated employment effective immediately on August 10, 2026, under circumstances entitling him to severance pay and benefits. The press release confirms his departure and announces Paul Verrastro as interim replacement, citing \"revised commercial outlook and need to improve commercial execution\" as the reason for the leadership change. This is a material departure of a named executive officer responsible for revenue generation at a commercial-stage medical device company.","company_name":"CVRx, Inc.","ticker":"CVRX","filing_date":"2026-08-11","form":"8-K","submitted_at":null,"items":[{"id":28136,"accession_number":"0001104659-26-093721","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Robert John, Chief Revenue Officer, terminated employment effective immediately on August 10, 2026, under circumstances entitling him to severance pay and benefits. The press release confirms his departure and announces Paul Verrastro as interim replacement, citing \"revised commercial outlook and need to improve commercial execution\" as the reason for the leadership change. This is a material departure of a named executive officer responsible for revenue generation at a commercial-stage medical device company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T11:10:39.680355+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28136,"accession_number":"0001104659-26-093721","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Robert John, Chief Revenue Officer, terminated employment effective immediately on August 10, 2026, under circumstances entitling him to severance pay and benefits. The press release confirms his departure and announces Paul Verrastro as interim replacement, citing \"revised commercial outlook and need to improve commercial execution\" as the reason for the leadership change. This is a material departure of a named executive officer responsible for revenue generation at a commercial-stage medical device company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T11:10:39.680355+00:00","company_name":"CVRx, Inc.","ticker":"CVRX","filing_date":"2026-08-11"}]}